Integral Biosystems

Integral BioSystems, established in 2011 and headquartered in Bedford, Massachusetts, is a prominent contract research organization specializing in pharmaceutical drug development and related services. With a sprawling 10,000 square foot facility, the company excels in creating complex formulations and dosage forms for various applications, including ophthalmic, dermal, injectable, otic, pulmonary, intranasal, and rectal dose forms. Their expertise extends to sustained release drug development, featuring technologies like injectable microspheres, liposomes, hydrogels, nano-complexes, and micro/nanocrystals. Integral BioSystems' services encompass formulation development, analytical method development, scale-up/technology transfer, and licensable technologies for enhanced drug delivery. Their team's extensive experience in drug formulation and development, complemented by a remarkable track record of success, sets them apart in the industry. The company is dedicated to advancing drug delivery through cutting-edge research and development, establishing itself as a trusted partner in pharmaceutical development. Integral BioSystems' profound impact on the pharmaceutical industry is evidenced by their credibility and significant track record. Their mission to facilitate the seamless transition of research concepts to clinic-ready products, coupled with their commitment to innovation, quality, and client satisfaction, positions them as industry leaders. Underpinning these efforts is a team of highly skilled professionals dedicated to driving innovation in pharmaceutical drug development and delivery.